Insights

Gathering insights about Caribou…

Similar companies to Caribou

Caribou Tech Stack

Caribou uses 8 technology products and services including Google Fonts API, LogMeIn, Vue.js, and more. Explore Caribou's tech stack below.

Google Fonts API
Font Scripts
LogMeIn
Help Desk Management
Vue.js
Javascript Frameworks
jQuery-pjax
Mobile Frameworks
TypeScript
Programming Languages
reCAPTCHA
Security
Nginx
Web Servers
Facebook
Widgets

Media & News

Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026
-- Single dose of vispa-cel produced durable responses in 2L LBCL patients: 82% ORR, 67% CR rate, and 17.1-month mPFS -- -- Generally well-tolerated safety profile continues to support outpatient administration and further expansion to community centers --
Jun 11, 2026 | www.globenewswire.com
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting
-- Single dose of CB-011 produced deep, durable responses in heavily pretreated, BCMA-naïve patients with r/r MM: 83% CR rate, 91% MRD negativity, and 50% of patients in ≥CR at 15 months -- -- Case study of a patient who previously received an anti-BCMA CAR-T showed an early complete response that was ongoing as of the data cutoff date -- -- EHA oral presentation scheduled for Sunday, June 14, 2026, at 11:00am CEST -- -- CaMMouflage phase 1 initial dose expansion data in BCMA-naïve and BCMA-exposed patients expected in H2 2026 -- BERKELEY, Calif.
Jun 11, 2026 | www.globenewswire.com
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting
-- Single dose of CB-011 produced deep, durable responses in heavily pretreated, BCMA-naïve patients with r/r MM: 83% CR rate, 91% MRD negativity, and 50% of patients in ≥CR at 15 months -- -- Case study of a patient who previously received an anti-BCMA CAR-T showed an early complete response that was ongoing as of the data cutoff date --
Jun 11, 2026 | www.globenewswire.com
Caribou Biosciences Says CRISPR CAR-T Is Pivotal-Ready, CB-011 Data Nears
Caribou Biosciences NASDAQ: CRBU Chief Executive Officer Rachel Haurwitz said the company is advancing two CRISPR-enabled, off-the-shelf CAR T cell therapy programs, with its lymphoma candidate vispa-cel now “pivotal-ready” and its multiple myeloma program CB-011 continuing in Phase 1 development.
Jun 09, 2026 | www.marketbeat.com
Caribou Biosciences, Inc. (CRBU) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Caribou Biosciences, Inc. (CRBU) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Jun 05, 2026 | seekingalpha.com
Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference
BERKELEY, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou's president and chief executive officer, will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026, at 2:35pm ET in New York.
May 27, 2026 | www.globenewswire.com
Caribou Biosciences, Inc. (CRBU) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Caribou Biosciences, Inc. (CRBU) Presents at Bank of America Global Healthcare Conference 2026 Transcript
May 15, 2026 | seekingalpha.com

Caribou's Email Address Formats

Caribou uses at least 1 format(s):

Caribou Email Formats	Example	Percentage
First@caribouwealth.com	John@caribouwealth.com	100%

Frequently Asked Questions

Where is Caribou's headquarters located?

Caribou's main headquarters is located at San Francisco, California United States. The company has employees across 1 continents, including North America.

What is Caribou's stock symbol?

Caribou is a publicly traded company; the company's stock symbol is CRBU.

What is Caribou's official website and social media links?

Caribou's official website is caribouwealth.com and has social profiles on LinkedIn Crunchbase.

What is Caribou's NAICS code?

Caribou's NAICS code is 52 - Finance and Insurance.

How many employees does Caribou have currently?

As of June 2026, Caribou has approximately 29 employees across 1 continents, including North America. Key team members include Health Plan Coordinator: C. M.. Explore Caribou's employee directory with LeadIQ.

What industry does Caribou belong to?

Caribou operates in the Financial Services industry.

What technology does Caribou use?

Caribou's tech stack includes Google Fonts APILogMeInVue.jsjQuery-pjaxTypeScriptreCAPTCHANginxFacebook.

What is Caribou's email format?

Caribou's email format typically follows the pattern of First@caribouwealth.com. Find more Caribou email formats with LeadIQ.

Caribou

Q: What is Caribou's official website and social media links?

Caribou's official website is caribouwealth.com. Caribou has social profiles on LinkedIn.

Q: How many employees does Caribou have currently?

Caribou has approximately 29 employees.

Q: What technology does Caribou use?

Caribou's tech stack includes Figma, Amazon Web Services, HubSpot Analytics, Google Tag Manager, OpenResty.

Q: What is Caribou's NAICS code?

Caribou's NAICS code is 52 (Finance and Insurance).

Financial ServicesCalifornia, United States11-50 Employees

Caribou was successfully acquired by Move Health in January 2025.

Company Overview

Headquarters: San Francisco, California United States
Website: caribouwealth.com
Stock Symbol: CRBU
NAICS Code: 52 - Finance and Insurance
Employees: 11-50

Media & News

Funding & Financials

$1M
Caribou's revenue is estimated to be in the range of $1M

Funding & Financials

$1M
Caribou's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Caribou

Horizon Digital Finance LLC d/b/a myAutoloan.com

Credible

NerdWallet

Auto Credit Express

Caribou Tech Stack

Media & News

Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026

Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting

Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting

Caribou Biosciences Says CRISPR CAR-T Is Pivotal-Ready, CB-011 Data Nears

Caribou Biosciences, Inc. (CRBU) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference

Caribou Biosciences, Inc. (CRBU) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Caribou's Email Address Formats

Frequently Asked Questions

Where is Caribou's headquarters located?

What is Caribou's stock symbol?

What is Caribou's official website and social media links?

What is Caribou's NAICS code?

How many employees does Caribou have currently?

What industry does Caribou belong to?

What technology does Caribou use?

What is Caribou's email format?

Caribou

Company Overview

Media & News

Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026

Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting

Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?